Mark T. Bertolini, Chief Executive Officer at Oscar Health, Inc. (OSCR), sold 1,206,310 shares at $28.60 ($34.9M) on 2026-06-25, disclosed to the SEC on 2026-06-29.
Scheduled sale ($34.9M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.60 | 597,942 | $17.1M | 49.0% |
| 2 | $29.08 | 17,200 | $500K | 1.4% |
| 3 | $29.11 | 441,373 | $12.8M | 36.8% |
| 4 | $29.79 | 149,795 | $4.5M | 12.8% |
| Total | $28.94 avg | 1,206,310 | $34.9M | 100% |
| Filing → |
| AET | SELL | 2017-05-18 | $29.2M | — | Filing → |
| AET | SELL | 2016-05-04 | $3.8M | — | Filing → |
| AET | SELL | 2015-12-23 | $3.0M | — | Filing → |